Caution required with use of ritonavir-boosted PF-07321332 in COVID-19 management
Author:
Publisher
Elsevier BV
Subject
General Medicine
Reference5 articles.
1. Pharmacological and therapeutic properties of ritonavir-boosted protease inhibitor therapy in HIV-infected patients;Zeldin;J Antimicrob Chemother,2004
2. Pharmacokinetic enhancement in HIV antiretroviral therapy: a comparison of ritonavir and cobicistat;Renjifo;AIDS Rev,2015
3. Induction effects of ritonavir: implications for drug interactions;Foisy;Ann Pharmacother,2008
4. The complexities of antiretroviral drug-drug interactions: role of ABC and SLC transporters;Kis;Trends Pharmacol Sci,2010
Cited by 62 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. SARS‐CoV‐2 PLpro Inhibition: Evaluating in Silico Repurposed Fidaxomicin's Antiviral Activity Through In Vitro Assessment;ChemistryOpen;2024-08-05
2. Real-world effectiveness of molnupiravir, azvudine and paxlovid against mortality and viral clearance among hospitalized patients with COVID-19 infection during the omicron wave in China: A retrospective cohort study;Diagnostic Microbiology and Infectious Disease;2024-08
3. Network-based Multi-omics Disease–Drug Associations Reveal Drug Repurposing Candidates for Covid-19 Disease Phases;Drug Repurposing;2024-07-03
4. Simultaneous measurement of COVID-19 treatment drugs (nirmatrelvir and ritonavir) in rat plasma by UPLC-MS/MS and its application to a pharmacokinetic study;Heliyon;2024-06
5. New anti-SARS-CoV-2 aminoadamantane compounds as antiviral candidates for the treatment of COVID-19;Virus Research;2024-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3